Asset Dedication’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.04K Buy
51
+36
+240% +$5.68K ﹤0.01% 827
2026
Q2
$2.37K Buy
+15
New +$2.03K ﹤0.01% 1018
2025
Q4
– Sell
-235
Closed -$23.5K – 1178
2025
Q3
$23.5K Buy
+235
New +$21.2K ﹤0.01% 647
2019
Q2
– Sell
-450
Closed -$41K – 647
2019
Q1
$41K Buy
+450
New +$38.3K 0.01% 294

Other funds holding XBI

Asset Dedication's XBI Position: Q3 2026 in Review

Asset Dedication increased its State Street SPDR S&P Biotech ETF (XBI) stake by 240% in Q3 2026, buying an estimated $5.68K and bringing the position to 51 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Asset Dedication first reported a position in XBI in Q1 2019 and has held it in 4 quarters since. The position peaked at $41K in Q1 2019. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Asset Dedication held 51 shares of State Street SPDR S&P Biotech ETF worth $8.04K as of Q3 2026.
  • Asset Dedication bought 36 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $5.68K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #827 holding.
  • Asset Dedication first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 4 quarters since.
  • Asset Dedication's State Street SPDR S&P Biotech ETF position peaked at $41K in Q1 2019.
  • 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.